Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited ( T14.SI) - Dividend Growth Rate (DGR)
T14.SI Dividend Growth Rate for past 3 years (DGR3)
Dividend history for stock T14.SI (Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited) including dividend growth rate predictions based on history.
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 4.849USD | 154.93% |
| 2035 | 3.730USD | 119.18% |
| 2034 | 2.869USD | 91.68% |
| 2033 | 2.207USD | 70.52% |
| 2032 | 1.698USD | 54.25% |
| 2031 | 1.306USD | 41.73% |
| 2030 | 1.005USD | 32.10% |
| 2029 | 0.773USD | 24.69% |
| 2028 | 0.594USD | 18.99% |
| 2027 | 0.457USD | 14.61% |
| 2026 | 0.352USD | 11.24% |
T14.SI Dividend Growth Rate for past 5 years (DGR5)
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 4.849USD | 154.93% |
| 2035 | 3.730USD | 119.18% |
| 2034 | 2.869USD | 91.68% |
| 2033 | 2.207USD | 70.52% |
| 2032 | 1.698USD | 54.25% |
| 2031 | 1.306USD | 41.73% |
| 2030 | 1.005USD | 32.10% |
| 2029 | 0.773USD | 24.69% |
| 2028 | 0.594USD | 18.99% |
| 2027 | 0.457USD | 14.61% |
| 2026 | 0.352USD | 11.24% |
T14.SI Dividend Growth Rate for past 10 years (DGR10)
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 2.527USD | 80.74% |
| 2035 | 2.075USD | 66.29% |
| 2034 | 1.704USD | 54.43% |
| 2033 | 1.399USD | 44.69% |
| 2032 | 1.148USD | 36.69% |
| 2031 | 0.943USD | 30.12% |
| 2030 | 0.774USD | 24.73% |
| 2029 | 0.636USD | 20.31% |
| 2028 | 0.522USD | 16.67% |
| 2027 | 0.428USD | 13.69% |
| 2026 | 0.352USD | 11.24% |
T14.SI
Price: $3.13
Dividend Yield: 16.48%
Forward Dividend Yield: 22.48%
Dividend Per Share: 0.70 USD
Earnings Per Share: 0.68 USD
P/E Ratio: 4.71
Exchange: SES
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 4.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 16
DGR3: 30.00%
DGR5: 30.00%
DGR10: 21.80%